We are live on ! Find out more
PRQR icon

ProQR Therapeutics
PRQR

74 hedge funds and large institutions have $365M invested in ProQR Therapeutics in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 24 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 9

10% more funds holding

Funds holding: 67 → 74 (+7)

9% more capital invested

Capital invested by funds: $333M → $365M (+$31.4M)

8.76% more ownership

Funds ownership: 62.19% → 70.95% (+8.8%)

4% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 24

17% less call options, than puts

Call options by funds: $485K | Put options by funds: $584K

Holders
74
Holders Change
+7
Holders Change %
+10.45%
% of All Funds
1.14%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
18
Increased
25
Reduced
24
Closed
9
Calls
$485K
Puts
$584K
Net Calls
-$99K
Net Calls Change
-$925K

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$9.89M
2
GPP
Great Point Partners
Connecticut
+$8.31M
3
RI
RTW Investments
New York
+$4.45M
4
Goldman Sachs
Goldman Sachs
New York
+$3.67M
5
BlackRock
BlackRock
New York
+$3.3M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$10.2M
2
KA
Kerrisdale Advisers
Florida
-$3.33M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.52M
4
JP Morgan Chase
JP Morgan Chase
New York
-$1.84M
5
DCM
DAFNA Capital Management
California
-$1.61M
Name Holding Trade Value Shares
Change 		Change in
Stake
DADC
51
D.A. Davidson & Co
Montana
$126K +$120K +15,772 New
DU
52
Delphia (USA)
Ontario, Canada
$108K +$103K +13,480 New
Daiwa Securities Group
53
Daiwa Securities Group
Japan
$104K +$17.9K +2,352 +22%
Wells Fargo
54
Wells Fargo
California
$88K – – –
KAS
55
Kestra Advisory Services
Texas
$84K – – –
ProShare Advisors
56
ProShare Advisors
Maryland
$80K +$76.3K +10,020 New
CG
57
Cutler Group
California
$75K -$26.1K -3,434 -27%
IUHSA
58
Itau Unibanco Holding S.A.
Brazil
$57K -$19.1K -2,508 -26%
DWA
59
Dorsey Wright & Associates
California
$55K +$52.2K +6,860 New
Northern Trust
60
Northern Trust
Illinois
$51K +$48.2K +6,330 New
US Bancorp
61
US Bancorp
Minnesota
$43K +$13.2K +1,736 +47%
QCG
62
Quadrant Capital Group
Ohio
$31K +$9.11K +1,196 +45%
BNP Paribas Financial Markets
63
BNP Paribas Financial Markets
France
$18.6K +$17.7K +2,326 New
LC
64
Lindbrook Capital
California
$16K -$109K -14,311 -88%
S
65
SignatureFD
Georgia
$16K +$404 +53 +3%
TRCT
66
Tower Research Capital (TRC)
New York
$16K +$14.7K +1,934 New
SWM
67
Spire Wealth Management
Virginia
$16K +$15.2K +2,001 New
TCWM
68
Total Clarity Wealth Management
Illinois
$12K +$11.4K +1,500 New
BHWM
69
Beaird Harris Wealth Management
Texas
$8K +$7.61K +999 New
CSS
70
Cubist Systematic Strategies
Connecticut
$6K -$183K -24,058 -97%
PA
71
Parallel Advisors
California
$6K +$5.73K +752 +4,178%
EWM
72
Edge Wealth Management
New York
$2K – – –
Northwestern Mutual Wealth Management
73
Northwestern Mutual Wealth Management
Wisconsin
$1K +$1.27K +167 New
GCP
74
GSA Capital Partners
United Kingdom
– -$1.15M -137,003 Closed
Two Sigma Investments
75
Two Sigma Investments
New York
– -$1.12M -133,941 Closed
1 2
3
4

PRQR Hedge Fund Activity: Q4 2021 in Review

74 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q4 2021, worth a combined $365M — up 9.4% from $333M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new PRQR positions and 9 closed out — a net gain of 9 holders — while 25 added to existing stakes and 24 trimmed.

The largest buyer was Cowen and Company, adding an estimated $9.89M. The largest seller was Wellington Management Group, cutting an estimated $10.2M.

  • 74 institutional investors held ProQR Therapeutics (PRQR) as of Q4 2021, up from 67 in Q3 2021.
  • Funds reported $365M of ProQR Therapeutics stock for Q4 2021, up 9.4% quarter-over-quarter.
  • 18 funds opened new ProQR Therapeutics positions in Q4 2021 and 9 closed out, a net change of +9 holders.
  • The largest ProQR Therapeutics buyer in Q4 2021 was Cowen and Company, an estimated $9.89M added.
  • The largest ProQR Therapeutics seller in Q4 2021 was Wellington Management Group, an estimated $10.2M sold.

Based on aggregated 13F filings for Q4 2021.